Fig. 2From: Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literaturePost treatment scan showing a residual mass in the fundus of gallbladder with normal liver and b residual mass in segment V of gallbladder with normal liver and absence of nodesBack to article page